Atrash, Shebli http://orcid.org/0000-0003-4547-7534
Robinson, Myra
Slaughter, Daniel
Aneralla, Amanda
Brown, Taylor
Robinson, Jordan
Ndiaye, Ami
Sprouse, Chelsea
Zhang, Qing
Symanowski, James T.
Friend, Reed
Voorhees, Peter M.
Usmani, Saad Z.
Bhutani, Manisha
Article History
Received: 29 May 2018
Revised: 16 October 2018
Accepted: 23 October 2018
First Online: 8 November 2018
Conflict of interest
: S.Z.U. reports consulting for Abbvie, Amgen, BMS, Celgene, Janssen, Takeda, Sanofi, and SkylineDx; speaker’s fees for Amgen, Celgene, Janssen, and Takeda; and research funding from Amgen, Array Biopharma, BMS, Celgene, Janssen, Pharmacyclics, Sanofi, and Takeda. P.M.V. reports consulting for Celgene, Millennium Takeda, BMS, Novartis, Array Biopharma, and Janssen; research funding from GSK, Janssen, Merck, Amgen, Oncopeptides, and Acetylon. S.A. reports consulting for Celgene, and Takeda, speaker’s fees for Takeda. M.B. reports speaker’s fees for Amgen; institutional clinical trial funding from Prothena, Janssen, and MedImmune.